Societal CDMO, Inc.

NASDAQ:SCTL

1.1 (USD) • At close April 5, 2024
Bedrijfsnaam Societal CDMO, Inc.
Symbool SCTL
Munteenheid USD
Prijs 1.1
Beurswaarde 116,130,300
Dividendpercentage 0%
52-weken bereik 0.26 - 1.28
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. J. David Enloe Jr.
Website https://www.societalcdmo.com

An error occurred while fetching data.

Over Societal CDMO, Inc.

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization,

Vergelijkbare Aandelen

Omega Therapeutics, Inc. logo

Omega Therapeutics, Inc.

OMGA

1.43 USD

INmune Bio, Inc. logo

INmune Bio, Inc.

INMB

5.19 USD

Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc.

ATOS

1.42 USD

Vascular Biogenics Ltd. logo

Vascular Biogenics Ltd.

VBLT

0.156 USD

FONAR Corporation logo

FONAR Corporation

FONR

17.4 USD

Portage Biotech Inc. logo

Portage Biotech Inc.

PRTG

9.91 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)